Search clinical trials for: Adrenergic alpha-2 Receptor Antagonists

Total 16488 results

Ocuphire Pharma, Inc.
Viatris Inc.

Recruiting

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2)

Mesopic Vision | Night Vision Loss

United States
Sheba Medical Center

Withdrawn

The Effectiveness of Idazoxan in Treating TRD

Major Depressive Disorder

Israel
Johns Hopkins University
Fast Grants

Terminated

Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) (PREVENT)

COVID-19

United States
Benha University

Completed

Double J Stenting and Sildosin After URSL for Lower Ureteric Stones (DJ)

Lower Ureteric Stones | Ureteroscopic Lithotripsy | DJ Stenting

Egypt
Ain Shams University

Completed

Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering

Shivering

Egypt
Charite University, Berlin, Germany

Completed

Influence of the Noradrenergic System on the Formation of Intrusive Memories

Intrusive Memories

Germany
Charite University, Berlin, Germany
German Federal Ministry of Education and Research

Recruiting

Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin

Posttraumatic Stress Disorder

Germany
Boehringer Ingelheim

Completed

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

Prostatic Hyperplasia
Mansoura University
Amiri Hospital

Not yet recruiting

Silodosin vs Placebo in the Treatment of Female LUTS

Lower Urinary Tract Symptoms
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Gundersen Lutheran Medical Foundation

Unknown

Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms

Ureteral Diseases

United States
Sohag University

Recruiting

The Efficacy of Dexmedetomidine Versus Labetalol In Providing Controlled Hypotension In Dacryocystorhinostomy SurgeryA Comparative Randomized Prospective Study

Nasolacrimal Duct Obstruction

Egypt
Imperial College London
GlaxoSmithKline

Terminated

I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD (I2PETPG)

Alzheimer Disease

United Kingdom
Soroka University Medical Center

Unknown

The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones

Renal Colic

Israel
University of Chicago

Withdrawn

Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed

Emergence From Anesthesia

United States
Hospices Civils de Lyon

Completed

[11C]Yohimbine PET Study of alpha2-AR ([11C]Yohimbine)

Healthy Controls

France
Gilead Sciences

Terminated

DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension (Darusentan)

Hypertension

United States, Argentina, Australia, Brazil
University of Aarhus
The Danish Medical Research Council; Fund for Advancement of Medical Science; Max Woerzner's Research Award

Completed

PET Neuroimaging of [11C]Mirtazapine

Mental Disorders | Mood Disorders | Affective Disorders | Depressive Disorders

Denmark
Sumitomo Pharma (Suzhou) Co., Ltd.

Terminated

The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine

Schizophrenia

China
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients

Schizophrenia

China
Sumitomo Pharma Co., Ltd.

Completed

Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

Schizophrenia

Japan, Korea, Republic of, Malaysia, Taiwan
Sunovion

Completed

A Twelve Week, Open Label Extension Study in Patients With Schizophrenia

Schizophrenia

United States, Slovakia, France, Italy, Serbia, South Africa, Russian Federation
New York State Psychiatric Institute
Sunovion

Completed

Biosignatures of Latuda for Bipolar Depression

Bipolar Depression

United States
University of British Columbia

Completed

Lurasidone and Cognition in Bipolar I Disorder

Bipolar I Disorder

Canada
Sunovion

Completed

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex (PERSIST)

Bipolar I Disorder

United States, Croatia, Hungary, Poland, Serbia, Argentina, Japan, France, Slovakia, Australia, Russian Federation, Bulgaria, Chile, Czech Republic
Sunovion

Completed

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose (RESOLVE 1)

Major Depressive Disorder With Mixed Features

United States, Serbia, Ukraine, Russian Federation, United Kingdom
Sunovion

Completed

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Bipolar Depression

United States, Canada, Czech Republic, India, Lithuania, Peru, South Africa, France, Poland, Romania, Russian Federation, Ukraine, Colombia, Slovakia, Japan
Sunovion

Completed

Major Depressive Disorder With Mixed Features - Extension (RESOLVE3)

Major Depressive Disorder

United States
Sunovion

Completed

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States, Israel, Chile, South Africa, Argentina, Brazil, Croatia, Thailand
Sunovion

Completed

A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

Schizophrenia

United States
Sunovion

Completed

The Bioequivalence Of Two Different Lurasidone Formulations In Patients

Schizophrenia

United States
Getz Pharma

Not yet recruiting

Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi

Ureteric Stone of Lower Third of Ureter
Walter Ritter GmbH & Co

Completed

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

Erectile Dysfunction

Germany
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) (MARYLU)

Schizophrenia

Italy
Nazlin Walji

Recruiting

Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients (ELICE_BD)

Bipolar Disorder

United States, Canada, Japan, United Kingdom
New York State Psychiatric Institute
Columbia University

Completed

18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder

Bipolar Depression

United States
Standard Chem. & Pharm. Co., Ltd.

Completed

A Study of Lurasidone HCl in Subjects With Schizophrenia

Schizophrenia

Taiwan
Sunovion

Completed

Lurasidone Extended Use Study

Schizophrenia | Bipolar Disorder

Canada, Serbia, Colombia, Czech Republic, India, Lithuania, Slovakia, Ukraine, France, Romania, South Africa, Russian Federation
Sunovion

Completed

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 (PERSISTExt)

Bipolar I Disorder

United States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
Sunovion

Completed

A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia

Schizophrenia

United States
Sunovion

Completed

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Bipolar Depression

United States, Czech Republic, India, France, Romania, Russian Federation, South Africa, Ukraine
Sunovion

Completed

Lithium Drug-Drug Interaction Study With Lurasidone HCl

Schizophrenia

United States
Sunovion

Completed

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

United States
George Papanicolaou Hospital

Unknown

Esmolol Versus Dexmedetomidine During Intracranial Procedures

Intracranial Aneurysm | Intracranial Neoplasms

Greece
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia

Schizophrenia

China
Sumitomo Pharma (Suzhou) Co., Ltd.
Sunovion

Terminated

A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression

Bipolar I Depression

China
Sumitomo Pharma Co., Ltd.

Completed

A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

Bipolar I Disorder

Japan, Lithuania, Malaysia, Philippines, Russian Federation, Slovakia, Taiwan, Ukraine
Sunovion

Completed

A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia

Schizophrenia

United States
Sumitomo Pharma (Suzhou) Co., Ltd.
Xuhui Central Hospital, Shanghai

Completed

Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects

Schizophrenia

China
Sunovion

Completed

Lurasidone Pediatric Bipolar Study (Illuminate)

Bipolar I Depression

United States, Korea, Republic of, Bulgaria, Poland, Mexico, Puerto Rico, Colombia, Hungary, France, Philippines, Ukraine

Search clinical trials for: Adrenergic alpha-2 Receptor Antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations